期刊文献+

北京生物医药产业的跨越式发展:问题与对策 被引量:2

Leaping development of Beijing pharmaceutical industry: problems and countermeasures
下载PDF
导出
摘要 背景:生物医药产业是21世纪全球公认的最具有发展前景的国际化高技术产业之一,也是世界贸易增长最快的朝阳产业之一。目的:分析北京生物医药产业的发展现状,指出北京生物医药产业跨越式发展中存在的问题及相应的解决对策。方法:应用计算机检索百度文库、中国知网及手工检索学校图书馆内书籍2005至2014年间的文献,分析了北京生物医药产业目前的发展现状和存在的问题,并针对这些问题提出对北京生物医药企业实现跨越式发展有指导意义的观点与结论。结果与结论:近年来,北京生物医药产业发展迅速并取得了良好成果,但在实施跨越式发展过程中也存在着诸多问题,如产业基础较薄弱、企业创新主体地位还未显现、缺乏足够的资金投入等。针对这些问题,提出了不断优化调整产业结构、进一步优化所有制结构、加强技术创新、建设以企业为主体的研发体系、实施品牌扩展战略5方面对策,实现北京生物医药产业由战略产业向主导产业的跨越式发展,成为世界重要的研发中心、高端制造基地和市场中心。 BACKGROUND:The biomedical industry is recognized as one of the international high-tech industries with the most development prospects in the 21st century, is also one of the world’s sunrise industries with fastest trade growth. OBJECTIVE: To analyze the development of Beijing biomedical industry and to briefly state the problems and countermeasures in the leaping development of Beijing pharmaceutical industry. METHODS:A computer-based search of Baidu Library and CNKI as wel as manual retrieval of school library was done for literatures published from 2005 to 2014. Then, we analyzed the developmental status and existing problems of Beijing pharmaceutical industry, based on which, the guiding significance and conclusion on the leaping development of Beijing pharmaceutical industry was given. RESULTS AND CONCLUSION:In recent years, Beijing biomedical industry has developed rapidly and obtained good achievements, but there are stil problems in the implementation of the leapfrog development, such as poor industrial base, no innovative subject, and lack of funds. To solve these problems, we propose five countermeasures, that is, to constantly optimize and readjust the industrial structure, to further optimize the ownership structure, to enhance technological innovation, to build business-oriented research & development system, and to implement brand extension strategy, based on which, Beijing biomedical industry can realize the leapfrog development from strategic industry to leading industry, and become the world’s major research & development center, high-end manufacturing base and market center.
作者 孔妍 孙利华
出处 《中国组织工程研究》 CAS 北大核心 2015年第3期483-487,共5页 Chinese Journal of Tissue Engineering Research
关键词 生物材料 生物医药产业 跨越式发展 对策 综述 Tissue Engineering Biopharmaceutics
  • 相关文献

参考文献17

二级参考文献28

  • 1宿凌,李校堃.试论我国生物医药的发展环境[J].中国药房,2005,16(16):1209-1211. 被引量:4
  • 2干荣富.医药外包将推动我国医药经济的新一轮发展[J].中国医药工业杂志,2006,37(2). 被引量:4
  • 3曼鹿,杨智华.研发外包:医药企业的新契机[J].医药世界,2007(1):44-46. 被引量:4
  • 4中共北京市委编写纽.刘仁传[M].北京:北京出版社,2000.7.
  • 5伍建民,张京成,李梅.产业技术创新联盟与政策导向[M].北京:科学出版社,2011.
  • 6国家统计局.2009年第二次全国R&D资源清查资料汇编[M].北京:中国统计出版社,2009.
  • 7世界银行.全球经济展望报告(2012)[EB/OL].http://web. world bank. org/WBSITE/EXTERNAL/EXTDEC/EXTDECPROSPECTS/EXTGBLPROSPECTSAPRIL/0, conte.
  • 8国家发展改革委员会.生物产业发展“十一五”规划[EB/OL] .(2007 -07 -23) [2009 -05 -01] . http://www.ndrc.gov.cn/gjst;y/xxcy/t20070429_133388.htm.
  • 9生物医药发展战略报告(产业篇).北京:科学出版社,2009.
  • 10Konald J, Ogel V. Pharmaceutical economies and public policy.New York: The Haworth Press, 2007.

共引文献23

同被引文献25

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部